chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient began feeling light headed 5  minutes after being given the vaccine, then feeling tingling in hands then in body, he then started feeling tightness in stomach area then in arms. Patient was instructed to take deep breaths and was able to speak in full sentences when he was asked about his address and if he's had a reaction to vaccines in the past. He responded that he felt lightheaded after his Tetanus vaccine in the past but never severe reactions.  EMS was called and he was take to hospital by ambulance.
Reactivation of smallpox vaccination site approx 30 days following Hepatitis B vaccine. Injection in same arm smallpox vaccination received March 3, about 9 months prior to this response.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 025A21A) for COVID-19 vaccination. No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.  Concomitant drug information was not reported. Treatment medications were not reported.   This case was linked to MOD-2021-281226 (Patient Link).   Reporter did not allow further contact
Rash consisting of small, faint red bumps have formed on her chest, abdomin, and back. There does not appear to be any itching or pain associated with the bumps.
3 hours later broke out in really bad hives with welts all over my arm and the tattoo on my arm was swollen. I had a rash on my arms chest, stomach and down both sides of my legs and pain in my arms and pain in my lower back where I had my spine fusion. Shoulders both hurt in my joints. Headache for about 3 days.
Felt like a bee sting, arm got sore and heavy, tenderness to touch. fatigue, chills, fever, h/a, body aches. Got better each day.
"SM received second Pfizer dose of covid19 vaccination in right arm, lot EL1283 at approximately 1140.  Remained in auditorium for 15 minutes.  As SM was walking back to work location stated she had bilateral tingling in arms. SM returned to Vaccine Clinic and made contact with writer.  SM escorted to alcove for additional monitoring.  Upon further investigation SM stated she experienced itching in throat that was self limiting in initial 15 minutes.   VS 1200 L arm BP 167/92, HR 90, SpO2 97% 1202 SM states improvement in bilateral arm tingling. 1205 L arm BP 139/90, HR 96, SpO2 98% 1207 SM states complete resolution of bilateral arm tingling. 1210 L arm BP 144/91, HR 96, 99% SpO2 1215 ambulated with SM.  No return of symptoms. SM returned to work.
Patient came in 3/31/09 stated that the day he got vaccines 3/23/09 his legs both got swollen and purple. They took to urgent care, advised them just TYLENOL and cool compresses.
Patient had nausea and dizziness after the vaccine ; patient vomit but after that felt better and left the pharmacy
6 hrs p/vax devel pruritus w/swollen hands & painful joints; no urticaria or resp sx; treated w/DPH then pvt MD prescribed corticosteroids;
This spontaneous report as received from a pharmacist refers to a 70 year old female patient with relevant medical history included arrhythmia. On 04-JUL-2013 the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneously, lot # not reported, expiry date 06-MAR-2013. Concomitant therapies included TIKOSYN. Patient's relevant past drug history was unknown. The product had been quarantined, due to an unknown temperature excursion. The relevant laboratory data was unknown. At the time of report it was not known if she will continue to take ZOSTAVAX. Additional information has been requested.
Developed strange chest sensation, followed by hypersensitivity to touch on the left arm/chest/back (left arm was injection site) - approximately 3-4 days after getting my first Moderna shot.  Rash developed shortly after that, followed by hives and blisters similar to shingles.
Mixed Dose. Received Moderna Covid vaccine 04/07/21 and 05/05/21. Received Pfizer 3rd dose 09/02/21 secondary to immunocompromised state.
Patient reports feeling dizzy, mother indicates she is hypoglycemic and ate more than 3 hours ago. Doctor is notified, snack is offered and is monitored according to medical order.
pins and needles; skin feels wormed; sore arm; felt numbness in his fingertips; This isThis is a spontaneous report from a contactable consumer or other non-healthcare professional. A 32-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), via an unspecified route of administration on 10Aug2021 (Batch/Lot number and Expiry date was not reported) (at the age of 32-years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pins and needles, skin feels wormed, sore arm and felt numbness in his fingertips. The reporter stated that he did not want to report a side effect as it did not do him any good to just report it. He declined to complete report. He was calling in regard to the Pfizer COVID vaccine and wanted some information about a side effect. The reporter stated that his side effect was not the same day and it was the day after. He further stated that he received the vaccine on Tuesday 10Aug2021 and starting yesterday and today he felt pins and needles throughout his body as if he took pre-workout. His skin feels wormed like pins and needles or as if he took beta alanine or been in the sun too long, it varies in intensity. The reporter would like to know if this side effect has been reported and is it something that goes away. It was reported that on 10Aug2021 the day he received the vaccine he did not have many side effects and he did not really have a sore arm until the next day and he felt numbness in his fingertips on the same side he got the shot but that went away. Also stated that three hours prior to the receiving the shot he took a medication called meloxicam and he told the pharmacist initially and they did not think it would be an issue. After delivering response to question caller stated that was true and he knew that they have to cover themselves and this was a waste of time. Caller then disconnected call. Unable to offer survey as the call was disconnected. Unable to attempt to transfer again as the reporter disconnected call. He is 32-years-old male. Unable to ask for consent to contact as caller disconnected call. The clinical outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
After first shot notice a lump under my left armpit area. It didn?t quite go away and the after the second dose the lump got bigger and it?s a little tender this time. It?s been two days since the 2nd injection and doesn?t seem to be going down in size.
Severe headache on the side and back of my right eye. Took sinus medication thinking it was sinus pain.Then in continue to worsen with issues with sight in the right eye. Now having same pain in the left eye.
pt recv vax 12SEP97;pt devel muscle weakness in rt arm on day p/vax;
Emesis: the next day and the following day. Seizures: starting 3 days after vaccinations given and continued to have seizures until given KEPPRA. Hospitalized due to seizures.
Date the vial was initially stored in the refrigerator 05-Aug-2022 and date of administration of vaccine 06-Sep-2022 from 9:15 to 9:45; No adverse event; Patient received Moderna Covid-19 vaccine 30 days past its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine 30 days past its beyond use date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 05-Aug-2022 and date of administration of vaccine 06-Sep-2022 from 9:15 to 9:45) and NO ADVERSE EVENT (No adverse event) in a 23-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR92347B and AR9237B) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine 30 days past its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 05-Aug-2022 and date of administration of vaccine 06-Sep-2022 from 9:15 to 9:45) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine 30 days past its beyond use date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 05-Aug-2022 and date of administration of vaccine 06-Sep-2022 from 9:15 to 9:45) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid-19 vaccine 30 days past its beyond use date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator 05-Aug-2022 and date of administration of vaccine 06-Sep-2022 from 9:15 to 9:45).    Concomitant product use was not provided by the reporter.  The patient had no adverse reactions after first dose.  During the second dose, the patient received Moderna COVID-19 vaccine 30 days past its use by date. The vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-642057, US-MODERNATX, INC.-MOD-2022-642059, US-MODERNATX, INC.-MOD-2022-642869, US-MODERNATX, INC.-MOD-2022-642060 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2022: Live follow-up contains no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-642057:Same reporter US-MODERNATX, INC.-MOD-2022-642059:Same reporter US-MODERNATX, INC.-MOD-2022-642869:Same reporter US-MODERNATX, INC.-MOD-2022-642060:Same reporter
pt recv vax 25JUL97 & 3AUG97 pt devel red spots behind both ears;4AUG97 pt presented to a MD office w/a a diffuse macular & papular rash w/@ least 50 lesions & a fever of 102;there was one small blister on one of the lesions by earlobe;
Patient was vaccinated at physician's office with DTaP on 12/4/2007.  Mother reports child developed a quarter sized local reaction at the injection site the following day.  This reaction progressed to orange-sized swelling with blisters two days later.  Also, reports that child developed peri-orbital swelling and blistering in the oral cavity within 1 week.  Child currently unable to swallow foods/ liquids, and is going to be taken to the ER today.
Low-grade fever, chills, lethargy, muscle soreness; Low-grade fever, chills, lethargy, muscle soreness; Low-grade fever, chills, lethargy, muscle soreness; Low-grade fever, chills, lethargy, muscle soreness; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old female patient received the second dose of bnt162b2 (BNT162B2 also reported as product COVID 19 brandPfizer, lot EL9265), via an unspecified route of administration in left arm on 30Jan2021 13:30 at SINGLE DOSE for Covid-19 immunisation. Medical history included MAC (mycobacterium avium complex) and allergic to strawberries. She had her first dose of bnt162b2 (lot EL3246) on 09Jan2021 in the left arm. The patient's concomitant medications were not reported. The patient previously took rifampin and and experienced, both had drug allergy. On 31Jan2021 12:00, the patient experienced low-grade fever, chills, lethargy, muscle soreness with no treatment. The outcome of events was unknown.
Information has been received from a pharmacist concerning a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not provided. The patient was vaccinated with GARDASIL (lot#, expiration date, dose and route not provided) on the following dates: the first dose on 10-JUL-2007, the second dose on 21-AUG-2008 (inappropriate schedule of vaccine administration), the third dose on 10-JAN-2010 (inappropriate schedule of vaccine administration). On 21-JAN-2016, the patient administered a dose of GARDASIL 9. No adverse effects were reported. Additional information has been requested.
Shingles; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number ER5ZB, expiry date 9th June 2021) for prophylaxis.   Co-suspect products included MMR (Measles mumps rubella vaccine) for prophylaxis.   On 17th May 2019, the patient received the 1st dose of Shingrix and Measles mumps rubella vaccine. On 6th June 2019, 20 days after receiving Shingrix and Measles mumps rubella vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix and Measles mumps rubella vaccine.  Additional information received were as follows: The patient broke out with shingles. The batch number of Shingrix was reported as ER52B from the reporter, however, based on a safety lot number review, the batch number was updated to ER5ZB. The reporter consented to follow up.
Patient arrived at vaccine site at approximately 1535 reporting that she had received the Janssen COVID vaccine approximately 3 months ago but was not given proof of vaccination. She requested to receive the Pfizer COVID vaccine as she is required to have proof of COVID vaccination. PHN called PHN supervisor and the medical team. Dr. from the medical team approved Pfizer vaccine series for the patient. Patient returned to vaccine site and received dose 1 of the Pfizer COVID vaccine (lot FF8839) at approximately 1800. Patient wait in observation area for 15min, no report of adverse symptoms. Patient left walking with steady gait at approximately 1815.
Pt requested PPD test & Hep A - after giving 2 Tdap & 2 PPD right before said patient, a Tdap was given instead of Hep A. Pt. was notified immediately & appt. for Hep A was made. Pt scheduled 1 mo. from incident. No concerns from patient.
multiple sclerosis diagnosis; This case was reported by a pharmacist via call center representative and described the occurrence of multiple sclerosis in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd April 2019, the patient received the 1st dose of Shingrix. On an unknown date, 46 days after receiving Shingrix, the patient experienced multiple sclerosis (serious criteria GSK medically significant). On an unknown date, the outcome of the multiple sclerosis was unknown.   It was unknown if the reporter considered the multiple sclerosis to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that the patient received Shingrix and was diagnosed with Multiple Sclerosis a month before the date of reporting. The exact date of multiple sclerosis diagnosis was unknown. The health care professional did not have the lot number and expiry date.
Inappropriate schedule of vaccine; Pain at injection site/painful; This case was reported by a consumer and described the occurrence of injection site pain in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received in January 2018, refer case US2019AMR159031).   On 29th August 2019, the patient received the 2nd dose of Shingrix. In August 2019, less than a day after receiving Shingrix, the patient experienced injection site pain. On 29th August 2019, the patient experienced drug dose administration interval too long. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were provided as follows: The patient had an opportunity to move to and forgot to go back for my 2nd followup vaccination, which patient finally did the day before reporting, which led to which led to lengthening of the vaccination schedule. The reaction to my second dose was much more painful than initial one, in terms of second-day pain at injection site.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Nov2022 at 13:00 as dose 4 (booster), single (Lot number: GJ6739) at the age of 76 years, in right arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Heart patient" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN, start date: 15Nov2000; TAMSULOSIN, start date: 01Oct2010; ESCITALOPRAM, start date: 01Mar2017. Past drug history included: Morphine, reaction(s): "Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (10Aug2023) negative, notes: tested negative on the 7th day; (11Aug2023) positive, notes: tested positive in the morning of the 8th day. Therapeutic measures were taken as a result of drug ineffective, COVID-19. Additional information: the patient took Paxlovid for 5 days, started feeling better on the 3rd day, and tested negative on the 7th day. He tested positive on the morning of the 8th day, not feeling well again. He had the same symptoms prior to taking Paxlovid.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Skin of left arm below deltoid to crease of elbow was red, swollen and warm to the touch possibly indicating cellulitis or an infection.
ITCHING ON LEGS,CHEST,BACK; RASH ON SEVERAL PARTS OF THE BODY; This spontaneous report received from a patient concerned a 41 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022 expiry: 25-MAY-2021) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, the subject experienced itching on legs, chest, back. On 15-MAR-2021, the subject experienced rash on several parts of the body. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching on legs, chest, back, and rash on several parts of the body. This report was non-serious.
No adverse event noted - Nurse accidently administered the Hib vaccine Subcutaneously instead of intramuscular. Reporting due to inappropriate site used in administration of vaccine.
patient got a dose of expired Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number J9B25, expiry date 14-SEP-2023) for prophylaxis.   On 12-OCT-2023, the patient received Shingrix. On 12-OCT-2023, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: patient got a dose of expired Shingrix).  The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 12-OCT-2023 Nurse reported the patient got a dose of expired Shingrix, which led to expired vaccine used. The reporter consented to follow up.
This spontaneous report was received from a physician via company representative regarding a 8 year and 9 months old Child patient. There was no information regarding concomitant medication, historical medication and concurrent condition. On an unknown date the 8 year and 9 months old Child patient was vaccinated with GARDASIL 9 for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported.
Vaccine was administered on a Friday. Saturday, muscle and joint pain began. Sunday it was so bad I couldn?t turn my head and was having chest pain and shortness of breath. I?m went to urgent care and received prednisone and cyclobenzaprine. Over the next few days I started to feel better. The following Thursday (6 days post vaccine) the chest pain and shortness of breath returned. I went to the ER. They did an EKG, chest X-ray, and check Triponin. All were normal. Saw my promary care doctor and was diagnosed with pleuritis, likely an inflammatory response to the vaccine. Shortness of breath and chest pain persist upon exertion.
Parent concerned for reaction/illness from GARDASIL vaccine. States that since the vaccine has had syncopal episodes, dizziness, vomiting, nausea, chest palpitations, excess sleep, lack of concentration, suicide attempt, major depression. FH: + depression, + sibling Asperger's.